Trial Profile

The Relative Oral Bioavailability of a Tablet Formulation vs a Solutionof PLN-74809 in Healthy Participants

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 25 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bexotegrast (Primary) ; Bexotegrast
Indications Idiopathic pulmonary fibrosis; Primary sclerosing cholangitis
Focus Adverse reactions
Sponsors Pliant Therapeutics

Most Recent Events

18 May 2022 According to a Pliant Therapeutics media release, data from this study were presented at the 2022 American Thoracic Society (ATS) International Conference.
01 Jul 2019 New trial record
27 Jun 2019 Results presented in the Pliant Therapeutics media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com